Diamedica Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Diamedica Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Diamedica Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Diamedica Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $92k | 13k | 6.87 |
| 2025-06-30 | $32k | 8.3k | 3.90 |
| 2025-03-31 | $17k | 4.4k | 3.79 |
| 2024-12-31 | $9.4k | 1.8k | 5.33 |
| 2024-09-30 | $53k | 13k | 4.19 |
| 2024-03-31 | $5.3k | 1.9k | 2.77 |
| 2023-09-30 | $216 | 84 | 2.58 |
| 2023-03-31 | $3.1k | 2.0k | 1.53 |
| 2022-12-31 | $5.9k | 3.8k | 1.58 |
| 2022-09-30 | $9.0k | 7.2k | 1.25 |
| 2022-06-30 | $6.0k | 3.0k | 1.98 |
| 2022-03-31 | $2.0k | 950 | 2.11 |
| 2021-12-31 | $17k | 4.6k | 3.68 |
| 2021-06-30 | $92k | 21k | 4.44 |
| 2021-03-31 | $10k | 1.1k | 9.52 |
| 2020-12-31 | $9.0k | 914 | 9.85 |
| 2020-06-30 | $4.0k | 589 | 6.79 |
| 2020-03-31 | $24k | 8.5k | 2.82 |
| 2019-09-30 | $5.0k | 2.4k | 2.12 |
| 2019-06-30 | $11k | 2.3k | 4.89 |
| 2018-12-31 | $4.0k | 1.3k | 3.02 |